Skip to main content
Journal cover image

Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023.

Publication ,  Journal Article
Zhang, AD; Anderson, TS; Hastings, SN
Published in: J Am Geriatr Soc
March 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Geriatr Soc

DOI

EISSN

1532-5415

Publication Date

March 2024

Volume

72

Issue

3

Start / End Page

942 / 945

Location

United States

Related Subject Headings

  • Humans
  • Geriatrics
  • Disease Progression
  • Demography
  • Cognitive Dysfunction
  • Clinical Trials as Topic
  • Alzheimer Disease
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, A. D., Anderson, T. S., & Hastings, S. N. (2024). Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023. J Am Geriatr Soc, 72(3), 942–945. https://doi.org/10.1111/jgs.18645
Zhang, Audrey D., Timothy S. Anderson, and S Nicole Hastings. “Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023.J Am Geriatr Soc 72, no. 3 (March 2024): 942–45. https://doi.org/10.1111/jgs.18645.
Zhang AD, Anderson TS, Hastings SN. Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023. J Am Geriatr Soc. 2024 Mar;72(3):942–5.
Zhang, Audrey D., et al. “Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023.J Am Geriatr Soc, vol. 72, no. 3, Mar. 2024, pp. 942–45. Pubmed, doi:10.1111/jgs.18645.
Zhang AD, Anderson TS, Hastings SN. Demographic characteristics of participants in clinical trials to treat Alzheimer disease, 2008-2023. J Am Geriatr Soc. 2024 Mar;72(3):942–945.
Journal cover image

Published In

J Am Geriatr Soc

DOI

EISSN

1532-5415

Publication Date

March 2024

Volume

72

Issue

3

Start / End Page

942 / 945

Location

United States

Related Subject Headings

  • Humans
  • Geriatrics
  • Disease Progression
  • Demography
  • Cognitive Dysfunction
  • Clinical Trials as Topic
  • Alzheimer Disease
  • 52 Psychology
  • 42 Health sciences
  • 32 Biomedical and clinical sciences